Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.

BACKGROUND: Most pediatric lipodystrophy data come from high-income/middle-income countries, but most HIV-infected children live in sub-Saharan Africa, where lipodystrophy studies have predominantly investigated stavudine-based regimens. METHODS: Three years after antiretroviral therapy (ART) initia...

ver descrição completa

Detalhes bibliográficos
Principais autores: Bwakura-Dangarembizi, M, Musiime, V, Szubert, A, Prendergast, A, Gomo, Z, Thomason, M, Musarurwa, C, Mugyenyi, P, Nahirya, P, Kekitiinwa, A, Gibb, D, Walker, A, Nathoo, K
Formato: Journal article
Idioma:English
Publicado em: Lippincott, Williams and Wilkins 2015

Registros relacionados